Multicolour dual-emission Photoluminescent Carbon Dots à la carte for biomedical applications

22 March 2023, Version 1

Abstract

Dual-emission fluorescence probes that provide high sensitivity are key for biomedical diagnostic applications. Non-toxic carbon dots (CDs) are a good alternative to traditional fluorescent probes, however robust and reproducible synthetic strategies are still needed to access materials with controlled emission profiles and improved fluorescence quantum yields (FQYs). Herein, we report a practical and general synthetic strategy to access dual-emission multicolour CDs with FQYs as high as 0.67 and green/blue, yellow/blue or red/blue excitation dependent emission profiles using common starting materials such as citric acid, cysteine and co-dopants to bias the synthetic pathway. Structural and physicochemical analysis is used to elucidate the material’s composition which is responsible for the unique observed photoluminescence properties. Moreover, the utility of the probes is demonstrated in the clinical setting by the synthesis of green/blue emitting antibody-CD conjugates which are used for the immunohistochemical staining of human brain tissues of glioblastoma patients, showing detection under two different emission channels.

Keywords

dual fluorescence nanoprobes • co-doped carbon dots • fluorescence modulation • glioblastoma detection • bioimaging

Supplementary materials

Title
Description
Actions
Title
Multicolour dual-emission Photoluminescent Carbon Dots à la carte for biomedical applications
Description
Herein, we report a practical and general synthetic strategy to access dual-emission multicolour CDs with FQYs as high as 0.67 and green/blue, yellow/blue or red/blue excitation dependent emission profiles using common starting materials such as citric acid, cysteine and co-dopants to bias the synthetic pathway. Structural and physicochemical analysis is used to elucidate the material’s composition which is responsible for the unique observed photoluminescence properties. Moreover, the utility of the probes is demonstrated in the clinical setting by the synthesis of green/blue emitting antibody-CD conjugates which are used for the immunohistochemical staining of human brain tissues of glioblastoma patients, showing detection under two different emission channels.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.